Tech Company Financing Transactions
Kardium Funding Round
On 1/26/2021, Kardium raised $115 million in funding from Fidelity Management & Research Company, T. Rowe Price and private investors.
Transaction Overview
Company Name
Announced On
1/26/2021
Transaction Type
Venture Equity
Amount
$115,000,000
Round
Undisclosed
Investors
Fidelity Management & Research Company (Lead Investor)
T. Rowe Price (Lead Investor)
Proceeds Purpose
Kardium plans to use money to accelerate commercial growth of the Globe System across Europe, and to conduct a clinical study for US Food and Drug Administration (FDA) approval of its system.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8518 Glenlyon Pkwy. 155
Burnaby BC, V5J 0B6
Canada
Burnaby BC, V5J 0B6
Canada
Phone
Website
Email Address
Overview
Kardium Inc. is a rapidly growing medical solutions company that has developed an advanced system for the treatment of atrial fibrillation (AF), which affects more than 37 million people worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Amos Michelson
Chief Executive Officer
Kevin Chaplin
President
Douglas Goertzen
Browse more venture capital transactions:
Prev: 1/26/2021: TScan Therapeutics venture capital transaction
Next: 1/26/2021: Riverlane venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs